Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats

• Published in: Nutrition research and practice Vol. 11; no. 6; pp. 470 - 478
• Main Authors: Koppula, Sushruta, Yum, Mun-Jeong, Kim, Jin-Seoub, Shin, Gwang-Mo, Chae, Yun-Jin, Yoon, Tony, Chun, Chi-Su, Lee, Jae-Dong, Song, MinDong
• Format: Journal Article
• Language: English
• Published: Korea (South) 한국영양학회 01.12.2017; The Korean Nutrition Society and the Korean Society of Community Nutrition
• Subjects: Original Research; 생활과학; apoptosis; silymarin; Liver; glutathione; hydroxyproline
• ISSN: 1976-1457; 2005-6168
• DOI: 10.4162/nrp.2017.11.6.470

A. Berger (Crassulaceae) has been used in traditional herbal medicines in Korea and other Asian countries to treat various diseases, including liver disorders. In the present study, the anti-fibrotic effects of extract (OJE) in cellular and experimental hepatofibrotic rat models were investigated. An hepatic stellate cells (HSCs) system was used to estimate cell viability, cell cycle and apoptosis by MTT assay, flow cytometry, and Annexin V-FITC/PI staining techniques, respectively. In addition, thioacetamide (TAA)-induced liver fibrosis was established in Sprague Dawley rats. Briefly, animals were divided into five groups (n = 8): Control, TAA, OJE 10 (TAA with OJE 10 mg/kg), OJE 100 (TAA with OJE 100 mg/kg) and silymarin (TAA with Silymarin 50 mg/kg). Fibrosis was induced by treatment with TAA (200 mg/kg, ) twice per week for 13 weeks, while OJE and silymarin were administered orally two times per week from week 7 to 13. The fibrotic related gene expression serum biomarkers glutathione and hydroxyproline were estimated by RT-PCR and spectrophotometry, respectively, using commercial kits. OJE (0.5 and 0.1 mg/mL) and silymarin (0.05 mg/mL) treatment significantly ( < 0.01 and < 0.001) induced apoptosis (16.95% and 27.48% for OJE and 25.87% for silymarin, respectively) in HSC-T6 cells when compared with the control group (9.09%). Further, rat primary HSCs showed changes in morphology in response to OJE 0.1 mg/mL treatment. In studies, OJE (10 and 100 mg/kg) treatment significantly ameliorated TAA-induced alterations in levels of serum biomarkers, fibrotic related gene expression, glutathione, and hydroxyproline ( < 0.05- < 0.001) and rescued the histopathological changes. OJE can be developed as a potential agent for the treatment of hepatofibrosis.